Drug

Coronavirus Drug and Treatment Tracker



The Covid-19 pandemic is one of the greatest challenges modern medicine has ever faced. Doctors and scientists are scrambling to find treatments and drugs that can save the lives of infected people and perhaps even prevent infection.

Below is an updated list of 19 of the most-talked-about treatments for the coronavirus. While some are accumulating evidence that they’re effective, most are still at early stages of research. We also included a warning about a few that are just bunk.






We are following 19 coronavirus treatments for effectiveness and safety:

Tentative or

mixed evidence

We are following 19 coronavirus treatments

for effectiveness and safety:

Tentative or

mixed evidence

We are following 19 coronavirus treatments

for effectiveness and safety:


There is no cure yet for Covid-19. And even the most promising treatments to date only help certain groups of patients, and await validation from further trials. The F.D.A. has not fully

Read More

How Scientists Got Coronavirus While Trying to Find a Drug for the Disease

In January, as a frightening new virus filled hospital wards in Wuhan, China, Stephanie Giordano, a 25-year-old researcher at the drugmaker Regeneron, in a suburb of New York City, began working on a treatment for the disease.

By March, the deadly coronavirus had hit home. Fearing she would get infected on the train that took her to the lab every day, she moved from her apartment in East Harlem to an Airbnb five minutes from the company’s headquarters in Tarrytown, in Westchester County.

Then her mother, a nurse’s assistant who cared for newborn babies at a Long Island hospital, was reassigned to a Covid-19 ward where she tended to older people struggling to breathe. No drug could help these patients — or her, if she were to get sick, too.

“I had somebody on the line that I really cared about,” Ms. Giordano said recently. “And I wanted to see

Read More

Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups

Twenty of the world’s largest pharmaceutical companies on Thursday announced the creation of a $1 billion fund to buoy financially strapped biotech start-ups that are developing new antibiotics to treat the mounting number of drug-resistant infections responsible for hundreds of thousands of deaths each year.

The fund, created in partnership with the World Health Organization and financed by drug behemoths that include Roche, Merck, and Johnson & Johnson, will offer a short-term but desperately needed lifeline for some of the three dozen small antibiotic companies, many of them based in the United States, that have been struggling to draw investment amid a collapsing antibiotics industry.

Over the past year, three American antibiotic start-ups with promising drugs have gone bankrupt, and many of the remaining companies are quickly running out of cash.

The new AMR Action Fund will make investments in roughly two dozen companies that have already identified a promising

Read More

Remdesivir, the First Coronavirus Drug, Gets a Price Tag

Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday.

The arrangement may serve as a template for distribution of new treatments and vaccines as the pandemic swells, said Ernst Berndt, a retired health economist at the Massachusetts Institute of Technology Sloan School of Management.

Remdesivir will be sold for $520 per vial, or $3,120 per treatment course, to hospitals for treatment of patients with private insurance, according to the Department of Health and Human Services and Gilead Sciences, the drug’s manufacturer.

The price will be set at $390 per vial, or $2,340 per treatment course, for patients on government-sponsored insurance and for those in other countries with national health care systems.

The drug will be sold only in the United States through September,

Read More